Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

OR

This facility is a member of


Connect with us:

Colon / Rectum / Anus Cancer

   

A Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorisn, Oxaleplatin (FOLFOX) and Bevacizumab in Patients with Locally-Advanced Rectal Cancer [ECOG 3204]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody Ramucinumab (IMC-1121B) in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy [ ECOG 7208]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

Statin Polyp Prevention Trial in Patients with Resected Colon Cancer [ NSABP P-5]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

 

Share